UAB "TBS Pharma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 1,639,364 |
| 255,751 |
| 138,517 |
| 123,067 |
| 19,199 |
| 20.81 |
| 7.51 |
| 153,704 |
| 431,224 |
| 21,054 |
| 563,874 |
| 2023 |
|---|
| 1,758,954 |
| 293,159 |
| 138,775 |
| 117,536 |
| 19,589 |
| 18.76 |
| 6.68 |
| 271,240 |
| 547,237 |
| 15,124 |
| 803,353 |
| 2024 |
|---|
| 1,589,674 |
| 293,298 |
| 94,243 |
| 80,065 |
| 14,772 |
| 18.79 |
| 5.04 |
| 351,305 |
| 650,120 |
| 9,983 |
| 991,442 |
Register and
explore Okredo data| 2024 |
|---|
| 1,589,674 |
| 293,298 |
| 94,243 |
| 80,065 |
| 14,772 |
| 18.79 |
| 5.04 |
| 351,305 |
| 650,120 |
| 9,983 |
| 991,442 |
Register and
explore Okredo data2024
Turnover (€)
1,589,674 €
-10 % *
Sales per employee (€)
293,298 €
0 % *
Profit before tax (€)
94,243 €-32 % *
Net Profit (€)
80,065 €-32 % *
Profit per employee (€)
14,772 €-25 % *
Total profitability (%)
18.79 %0.16 % *
Net profitability (%)
5.04 %-24.55 % *
Equity (€)
351,305 €30 % *
Amounts Payable And Liabilities (€)
650,120 €
19 % *
Non-current Assets (€)
9,983 €
-34 % *
CurrentAssets (€)
991,442 €23 % *